CARDIOVASCULAR RISK ASSESSMENT IN RHEUMATOID ARTHRITIS WITH NODULOSIS: APPROACH TO PRIMARY PREVENTION

CARDIOVASCULAR RISK ASSESSMENT IN RHEUMATOID ARTHRITIS WITH NODULOSIS: APPROACH TO PRIMARY PREVENTION

Cardiovascular risk assessment in patients with rheumatoid arthritis (RA) is challenging. Not all risk calculators adjust for RA status, yielding discording results. A 56-year-old woman with RA presented for bilateral pain and swelling in the metacarpophalangeal (MCP) and proximal interphalangeal (P...

Full description

Bibliographic Details
Main Authors:	Dinu Valentin Balanescu, Cristina Ileana Iosif, Andra Rodica Balanescu, Ruxandra Ionescu, Denisa Predeteanu
Format:	Article
Language:	English
Published:	Amaltea Medical Publishing House 2019-03-01
Series:	Romanian Journal of Rheumatology
Subjects:	abatacept cardiovascular risk assessment methotrexate nodulosis rheumatoid arthritis
Online Access:	https://revistemedicale.amaltea.ro/Romanian_Journal_of_RHEUMATOLOGY/Revista_Romana_de_REUMATOLOGIE-2019-Nr.1/RJR_2019_1_Art-06.pdf

Similar Items

RHEUMATOID NODULOSIS
by: Habibullah Khan
Published: (2015-06-01)

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
by: Rossella Talotta, et al.
Published: (2018-06-01)

Nodulose por Metotrexato Methotrexate Induced Nodulosis
by: Fernanda Guidolin, et al.
Published: (2005-08-01)

Nodulose acelerada na artrite reumatóide durante terapia com Leflunomida Accelerated nodulosis in rheumatoid arthritis during Leflunomide therapy
by: Dario Júnior de Freitas Rosa, et al.
Published: (2007-06-01)

Simultaneous occurrence of accelerated nodulosis in lungs, liver, and kidneys, and acute exacerbation of interstitial pneumonia in a patient with rheumatoid arthritis: an autopsy case report
by: Akitake Suzuki, et al.
Published: (2022-01-01)

Abatacept and cardiovascular risk in rheumatoid arthritis: update
by: T. V. Popkova
Published: (2018-01-01)

Impact of concomitant methotrexate on disease activity in patients with rheumatoid arthritis tapering abatacept: results from KOBIO registry
by: Jun Won Park, et al.
Published: (2024-07-01)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH DIFFERENT DURATION OF RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-01-01)

Immunological findings in relatives of patients with rheumatoid arthritis
by: Madalina-Pusa Duna, et al.
Published: (2019-12-01)

Retinal microvascular alterations in patients with active rheumatoid arthritis without cardiovascular risk factors: the potential effects of T cell co-stimulation blockade
by: Silvia Piantoni, et al.
Published: (2024-02-01)

Use of abatacept in rheumatoid arthritis
by: Johannes von Kempis, et al.
Published: (2012-05-01)

Efficacy, safety and tolerability of using abatacept for the treatment of rheumatoid arthritis
by: Rafael Venson, et al.
Published: (2012-12-01)

Experience with abatacept used in the treatment of patients with rheumatoid arthritis
by: V I Mazurov, et al.
Published: (2011-12-01)

EXPERIENCE OF TREATMENT WITH ABATACEPT IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

EXPERIENCE OF TREATMENT WITH ABATACEPT IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

Higher Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients Without Methotrexate Treatment
by: Karel Hloch, et al.
Published: (2021-11-01)

Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis
by: C. Derambure, et al.
Published: (2017-05-01)

Methotrexate in Treatment of Rheumatoid Arthritis
by: Wiewiόrowski Maciej, et al.
Published: (1999-08-01)

Azathioprine-induced accelerated cutaneous and pulmonary nodulosis in a patient with rheumatoid arthritis
by: Cristian Vera Kellet, et al.
Published: (2015-06-01)

Clinical, radiographic and molecular characterization of two unrelated families with multicentric osteolysis, nodulosis, and arthropathy
by: Tayyaba Ishaq, et al.
Published: (2023-09-01)

Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
by: Waka Yokoyama-Kokuryo, et al.
Published: (2020-03-01)

Sustained Long-Term Retention Rates of Abatacept in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis
by: Shuzo Sato, et al.
Published: (2021-08-01)

Cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy
by: E V Gerasimova, et al.
Published: (2014-05-01)

The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis
by: Alberto Floris, et al.
Published: (2025-01-01)

ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS: INTERNATIONAL DATA AND EXPERIENCE OF USAGE IN THE REPUBLIC OF MORDOVIA
by: L. A. Balykova, et al.
Published: (2014-03-01)

Cost-utility analysis of abatacept in rheumatoid arthritis in Italy
by: Simona de Portu, et al.
Published: (2008-03-01)

PENTOXIFILLIN INTHETREATMENTOF RHEUMATOID ARTHRITIS
by: I R Kolosova, et al.
Published: (2001-10-01)

Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease
by: Natalia Mena-Vázquez, et al.
Published: (2022-06-01)

Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study
by: Zento Yamada, et al.
Published: (2024-04-01)

Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive
by: Leslie R. Harrold, et al.
Published: (2024-01-01)

Impact of osteoporosis on the quality of life in patients with rheumatoid arthritis
by: Catalina Raluca Nuta, et al.
Published: (2020-06-01)

Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis
by: I. M. Marusenko, et al.
Published: (2019-03-01)

EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012-11-01)

Multicenter, observational clinical study of abatacept in Japanese patients with rheumatoid arthritis
by: Noriyoshi Ogawa, et al.
Published: (2019-01-01)

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018-03-01)

Safety and efficacy of abatacept among patients with refractory rheumatoid arthritis: Experience from a North Indian Tertiary Care Hospital
by: M N Arjun, et al.
Published: (2018-01-01)

Methotrexate use, not interleukin 33, is associated with lower carotid intima-media thickness in patients with rheumatoid arthritis
by: Maria Raquel Costa Pinto, et al.
Published: (2019-04-01)

Assessing the effects of distinct biologic therapies on rheumatoid arthritis pain by nociceptive, neuropathic and nociplastic pain components: a randomised feasibility study
by: Liban Ahmed, et al.
Published: (2024-05-01)

OSTEOPOROSIS IS ASSOCIATED WITH A LOWER PREVALENCE OF BODY MASS INDEX-DEFINED OBESITY IN RHEUMATOID ARTHRITIS
by: Catalina Raluca Nuta, et al.
Published: (2018-09-01)

A novel gene mutation for multicentric osteolysis nodulosis and arthropathy: Case report and review of literature
by: Marjan Shakiba, et al.
Published: (2023-04-01)